5,5-diphenyl-2-(2'-piperidinoethyl)-1,3-dioxolane-4-one a new drug with potent spasmolytic activity.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001249:Asthma / Q000139:chemically induced; D001285:Atropine / Q000494:pharmacology; D001464:Barium / Q000037:antagonists & inhibitors; D001794:Blood Pressure / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects; D002217:Carbachol / Q000037:antagonists & inhibitors; D002415:Cats; D002712:Chlorides / Q000037:antagonists & inhibitors; D004149:Dioxoles / Q000494:pharmacology*; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D006632:Histamine; D007082:Ileum / Q000187:drug effects; D007583:Jejunum / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects*; D009132:Muscles / Q000187:drug effects; D010208:Papaverine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology* / Q000633:toxicity; D010880:Piperidines / Q000494:pharmacology*; D011817:Rabbits; D012119:Respiration / Q000187:drug effects; D014630:Vagus Nerve / Q000502:physiology
D002712:Chlorides; D004149:Dioxoles; D010276:Parasympatholytics; D010880:Piperidines; D001464:Barium; D001285:Atropine; D006632:Histamine; D002217:Carbachol; D010208:Papaverine; D000109:Acetylcholine